Legal status · United States
Is Erythropoietin legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Erythropoietin is an approved medicine in the United States. Its legal category is "FDA-approved, prescription only". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 3 completed human trials are cited on its profile.
- People given it
- 4,641
- Found nothing
- 0
Legal category
FDA-approved, prescription only
Approved for anaemia caused by long-term kidney disease and some anaemias caused by chemotherapy. Its boxed warning says no one has found a haemoglobin target, dose or dosing plan that avoids the higher risks of death, heart attack, stroke, blood clots and tumour growth. Banned in sport.
Reviewed Sep 2026. This is a legal category, not legal advice.
A "research use only" label on a vial does not make it legal to use on people.
Erythropoietin in the United States at a glance
| Legal category | FDA-approved, prescription only |
|---|---|
| Note | Approved for anaemia caused by long-term kidney disease and some anaemias caused by chemotherapy. Its boxed warning says no one has found a haemoglobin target, dose or dosing plan that avoids the higher risks of death, heart attack, stroke, blood clots and tumour growth. Banned in sport. |
| FDA approval status | FDA approved since 1989 for anaemia (too few red blood cells), with the FDA's strongest (boxed) warnings. Checked on 11 September 2026: EPOGEN and PROCRIT (epoetin alfa, BLA 103234) approved 1 June 1989; ARANESP (darbepoetin alfa, BLA 103951) approved 17 September 2001; MIRCERA (BLA 125164) approved 14 November 2007; RETACRIT (BLA 125545) approved 15 May 2018. All listed Prescription. The boxed warning covers a higher risk of death, heart attack, stroke, blood clots in the veins, clots in the access point used for dialysis, and tumours growing or coming back. |
| Studies in people | 4 of 7 sources on the profile |
| Reviewed | Sep 2026 |
The legal category and note come from the Erythropoietin profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.
What this means
- 01
FDA has approved Erythropoietin for at least one use named on its label. So a proper pharmacy-grade product exists in the United States, and pharmacies hand it out on prescription.
- 02
Approval covers only the uses named on the label. Any other use is a prescriber's call. The approval itself does not cover it.
- 03
Unlicensed vials sold online, including those labeled "research use only", are not the approved product. The approval does not cover them.
What Erythropoietin is
Erythropoietin, or EPO, is the kidney hormone that tells your body to make red blood cells. It has been approved since 1989 for anaemia, meaning too few red blood cells. Three big studies tried pushing blood counts up to normal. They found harm, not benefit, including twice as many strokes in 4,038 people. Every product now carries the FDA's strongest warning.
EPO is a hormone made mainly by the kidneys when oxygen runs low. It tells the bone marrow to make more red blood cells.
How it works: In people, EPO docks on its receptor on young blood cells in the bone marrow. That keeps them alive and makes them multiply.
Approval history: FDA approved since 1989 for anaemia (too few red blood cells), with the FDA's strongest (boxed) warnings. Checked on 11 September 2026: EPOGEN and PROCRIT (epoetin alfa, BLA 103234) approved 1 June 1989; ARANESP (darbepoetin alfa, BLA 103951) approved 17 September 2001; MIRCERA (BLA 125164) approved 14 November 2007; RETACRIT (BLA 125545) approved 15 May 2018. All listed Prescription. The boxed warning covers a higher risk of death, heart attack, stroke, blood clots in the veins, clots in the access point used for dialysis, and tumours growing or coming back.
How FDA treats this kind of product
Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.
The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for Erythropoietin on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.
Erythropoietin in sport and the military
Whether Erythropoietin is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up Erythropoietin by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.
- WADA Prohibited List
- Global DRO (check a named product)
- USADA (US athletes)
- Operation Supplement Safety (US service members)
The rules you compete or serve under decide this, not this page.
Erythropoietin in other countries
Frequently asked questions
Is Erythropoietin legal in the United States?
Yes. Erythropoietin is an approved medicine in the United States. Its legal category is "FDA-approved, prescription only". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 3 completed human trials are cited on its profile. Note: Approved for anaemia caused by long-term kidney disease and some anaemias caused by chemotherapy. Its boxed warning says no one has found a haemoglobin target, dose or dosing plan that avoids the higher risks of death, heart attack, stroke, blood clots and tumour growth. Banned in sport.
Can I buy Erythropoietin in the United States?
Only with a prescription. In the United States, Erythropoietin has the legal category "FDA-approved, prescription only". Pharmacies hand it out with a prescription, for the use it is approved for. Buying it from unlicensed sellers online, or as a "research chemical", is outside that system. You get none of the protection the regulator gives. Note: Approved for anaemia caused by long-term kidney disease and some anaemias caused by chemotherapy. Its boxed warning says no one has found a haemoglobin target, dose or dosing plan that avoids the higher risks of death, heart attack, stroke, blood clots and tumour growth. Banned in sport.
Is Erythropoietin FDA approved?
Yes. FDA status: FDA approved since 1989 for anaemia (too few red blood cells), with the FDA's strongest (boxed) warnings. Checked on 11 September 2026: EPOGEN and PROCRIT (epoetin alfa, BLA 103234) approved 1 June 1989; ARANESP (darbepoetin alfa, BLA 103951) approved 17 September 2001; MIRCERA (BLA 125164) approved 14 November 2007; RETACRIT (BLA 125545) approved 15 May 2018. All listed Prescription. The boxed warning covers a higher risk of death, heart attack, stroke, blood clots in the veins, clots in the access point used for dialysis, and tumours growing or coming back.. Current US legal category: "FDA-approved, prescription only". On the evidence, 3 completed human trials are cited on its profile.
Related compounds in the United States
Full research profile
How Erythropoietin works, the studies we cite, FDA status and the full legal summary are all on its compound profile.
Erythropoietin profileThis page is general information about the legal status of Erythropoietin in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.